Zhiyong Cui1,2, Hui Feng1, Baichuan He1,2, Yong Xing1,2, Zhaorui Liu3, Yun Tian1. 1. Department of Orthopedic Surgery, Peking University Third Hospital, Beijing, China. 2. Peking University Health Science Center, Beijing, China. 3. Peking University Sixth Hospital, Beijing, China.
Abstract
BACKGROUND: It remains unclear whether an increased risk of type 2 diabetes (T2D) affects the risk of osteoarthritis (OA). METHODS: Here, we used two-sample Mendelian randomization (MR) to obtain non-confounded estimates of the effect of T2D and glycemic traits on hip and knee OA. We identified single-nucleotide polymorphisms (SNPs) strongly associated with T2D, fasting glucose (FG), and 2-h postprandial glucose (2hGlu) from genome-wide association studies (GWAS). We used the MR inverse variance weighted (IVW), the MR-Egger method, the weighted median (WM), and the Robust Adjusted Profile Score (MR.RAPS) to reveal the associations of T2D, FG, and 2hGlu with hip and knee OA risks. Sensitivity analyses were also conducted to verify whether heterogeneity and pleiotropy can bias the MR results. RESULTS: We did not find statistically significant causal effects of genetically increased T2D risk, FG, and 2hGlu on hip and knee OA (e.g., T2D and hip OA, MR-Egger OR = 1.1708, 95% CI 0.9469-1.4476, p = 0.1547). It was confirmed that horizontal pleiotropy was unlikely to bias the causality (e.g., T2D and hip OA, MR-Egger, intercept = -0.0105, p = 0.1367). No evidence of heterogeneity was found between the genetic variants (e.g., T2D and hip OA, MR-Egger Q = 30.1362, I 2 < 0.0001, p = 0.6104). CONCLUSION: Our MR study did not support causal effects of a genetically increased T2D risk, FG, and 2hGlu on hip and knee OA risk.
BACKGROUND: It remains unclear whether an increased risk of type 2 diabetes (T2D) affects the risk of osteoarthritis (OA). METHODS: Here, we used two-sample Mendelian randomization (MR) to obtain non-confounded estimates of the effect of T2D and glycemic traits on hip and knee OA. We identified single-nucleotide polymorphisms (SNPs) strongly associated with T2D, fasting glucose (FG), and 2-h postprandial glucose (2hGlu) from genome-wide association studies (GWAS). We used the MR inverse variance weighted (IVW), the MR-Egger method, the weighted median (WM), and the Robust Adjusted Profile Score (MR.RAPS) to reveal the associations of T2D, FG, and 2hGlu with hip and knee OA risks. Sensitivity analyses were also conducted to verify whether heterogeneity and pleiotropy can bias the MR results. RESULTS: We did not find statistically significant causal effects of genetically increased T2D risk, FG, and 2hGlu on hip and knee OA (e.g., T2D and hip OA, MR-Egger OR = 1.1708, 95% CI 0.9469-1.4476, p = 0.1547). It was confirmed that horizontal pleiotropy was unlikely to bias the causality (e.g., T2D and hip OA, MR-Egger, intercept = -0.0105, p = 0.1367). No evidence of heterogeneity was found between the genetic variants (e.g., T2D and hip OA, MR-Egger Q = 30.1362, I 2 < 0.0001, p = 0.6104). CONCLUSION: Our MR study did not support causal effects of a genetically increased T2D risk, FG, and 2hGlu on hip and knee OA risk.
Authors: Miranda L Davies-Tuck; Yuanyuan Wang; Anita E Wluka; Patricia A Berry; Graham G Giles; Dallas R English; Flavia M Cicuttini Journal: Maturitas Date: 2012-06-26 Impact factor: 4.342
Authors: F Eymard; C Parsons; M H Edwards; F Petit-Dop; J-Y Reginster; O Bruyère; P Richette; C Cooper; X Chevalier Journal: Osteoarthritis Cartilage Date: 2015-02-03 Impact factor: 6.576
Authors: Gibran Hemani; Jie Zheng; Benjamin Elsworth; Tom R Gaunt; Philip C Haycock; Kaitlin H Wade; Valeriia Haberland; Denis Baird; Charles Laurin; Stephen Burgess; Jack Bowden; Ryan Langdon; Vanessa Y Tan; James Yarmolinsky; Hashem A Shihab; Nicholas J Timpson; David M Evans; Caroline Relton; Richard M Martin; George Davey Smith Journal: Elife Date: 2018-05-30 Impact factor: 8.140
Authors: Georg Schett; Arndt Kleyer; Carlo Perricone; Enijad Sahinbegovic; Annamaria Iagnocco; Jochen Zwerina; Rolando Lorenzini; Franz Aschenbrenner; Francis Berenbaum; Maria-Antonietta D'Agostino; Johann Willeit; Stefan Kiechl Journal: Diabetes Care Date: 2012-09-21 Impact factor: 19.112
Authors: Jack Bowden; Fabiola Del Greco M; Cosetta Minelli; George Davey Smith; Nuala A Sheehan; John R Thompson Journal: Int J Epidemiol Date: 2016-12-01 Impact factor: 7.196